{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:07:14Z","timestamp":1788836834771,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ijid.2020.09.1445","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T12:07:24Z","timestamp":1601294844000},"page":"374-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["HEPCARE EUROPE- A case study of a service innovation project aiming at improving the elimination of HCV in vulnerable populations in four European cities"],"prefix":"10.1016","volume":"101","author":[{"given":"Gordana","family":"Avramovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1363-1680","authenticated-orcid":false,"given":"Maeve","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Mac\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff","family":"McCombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Oprea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair","family":"Story","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2411-0477","authenticated-orcid":false,"given":"Julian","family":"Surey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Sabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Bivegete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vickerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5404-2415","authenticated-orcid":false,"given":"John S","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2020.09.1445_bib0005","series-title":"Systematic Review on Hepatitis B and C prevalence in the EU\/EEA","author":"European Centre for Disease Prevention and C","year":"2016"},{"issue":"5","key":"10.1016\/j.ijid.2020.09.1445_bib0010","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S2468-1253(17)30045-6","article-title":"Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modeling study","volume":"2","author":"Razavi","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.ijid.2020.09.1445_bib0015","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/jvh.12844","article-title":"Establishing the cascade of care for hepatitis C in England-benchmarking to monitor the impact of direct-acting antivirals","volume":"25","author":"Simmons","year":"2018","journal-title":"J Viral Hepat"},{"issue":"Suppl 6","key":"10.1016\/j.ijid.2020.09.1445_bib0020","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1186\/1471-2334-14-S6-S16","article-title":"A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region","volume":"14","author":"Lazarus","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"February (1)","key":"10.1016\/j.ijid.2020.09.1445_bib0025","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12879-019-3748-2","article-title":"\u2019HepCheck Dublin\u2019: An Intensified Hepatitis C Screening Programme in a Homeless Population Demonstrates the Need for Alternative Models of Care","volume":"19","author":"Lambert","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2020.09.1445_bib0030","unstructured":"https:\/\/www.who.int\/hepatitis\/strategy2016-2021\/ghss-hep\/en\/23\/04\/2020."},{"key":"10.1016\/j.ijid.2020.09.1445_bib0035","unstructured":"http:\/\/www.hcvbrusselssummit.eu\/elimination-manifesto23\/4\/2020."},{"issue":"March (3)","key":"10.1016\/j.ijid.2020.09.1445_bib0040","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/17474124.2018.1424541","article-title":"Hepcare Europe - bridging the gap in the treatment of hepatitis C: study protocol","volume":"12","author":"Swan","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.ijid.2020.09.1445_bib0045","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3343\/alm.2013.33.3.184","article-title":"Performance evaluation of the OraQuick hepatitis C virus rapid antibody test","volume":"33","author":"Cha","year":"2013","journal-title":"Ann Lab Med"},{"issue":"6","key":"10.1016\/j.ijid.2020.09.1445_bib0050","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.2196\/resprot.9043","article-title":"Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care","volume":"7","author":"McCombe","year":"2018","journal-title":"JMIR Res Protoc"},{"issue":"November Suppl_5","key":"10.1016\/j.ijid.2020.09.1445_bib0055","first-page":"v24","article-title":"Integrating primary and secondary care to optimize hepatitis C treatment: development and evaluation of a multidisciplinary educational Masterclass series","volume":"74","author":"McCombe","year":"2019","journal-title":"J Ant Chem"},{"key":"10.1016\/j.ijid.2020.09.1445_bib0060","unstructured":"https:\/\/stats.oecd.org\/Index.aspx?DataSetCode=PRICES_CPI. 23\/4\/2020."},{"key":"10.1016\/j.ijid.2020.09.1445_bib0065","unstructured":"https:\/\/data.oecd.org\/gdp\/gross-domestic-product-gdp.htm 23\/4\/2020."},{"key":"10.1016\/j.ijid.2020.09.1445_bib0070","unstructured":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474124.2018.1424541 23\/4\/2020."},{"key":"10.1016\/j.ijid.2020.09.1445_bib0075","unstructured":"http:\/\/www.orasure.com\/products-infectious\/products-infectious-oraquick-hcv.asp 23\/4\/2020."},{"issue":"May","key":"10.1016\/j.ijid.2020.09.1445_bib0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jcv.2018.02.016","article-title":"Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance","volume":"102","author":"Pallar\u00e9s","year":"2018","journal-title":"J Clin Virol"},{"issue":"August (32)","key":"10.1016\/j.ijid.2020.09.1445_bib0085","doi-asserted-by":"crossref","first-page":"11033","DOI":"10.3748\/wjg.v20.i32.11033","article-title":"Chronic hepatitis C and liver fibrosis","volume":"20","author":"Sebastiani","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"January (1)","key":"10.1016\/j.ijid.2020.09.1445_bib0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/14656566.2017.1419185","article-title":"Advances in the treatment of HIV\/HCV coinfection in adults","volume":"19","author":"Schlabe","year":"2018","journal-title":"Expert Opin Pharmacother"},{"issue":"November (11)","key":"10.1016\/j.ijid.2020.09.1445_bib0095","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.2105\/AJPH.2012.300659","article-title":"Effectiveness of a Risk Screener in Identifying Hepatitis C Virus in a Primary Care Setting","volume":"102","author":"Drainoni","year":"2012","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.ijid.2020.09.1445_bib0100","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s13063-016-1501-3","article-title":"Hepatitis C\u2013assessment to treatment trial (HepCATT) in primary care: study protocol for a cluster-randomized controlled trial","volume":"17","author":"Roberts","year":"2016","journal-title":"Trials"},{"issue":"June (6)","key":"10.1016\/j.ijid.2020.09.1445_bib0105","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/add.14569","article-title":"The Hepatitis C Awareness Through to Treatment (HepCATT) study: improving the cascade of care for hepatitis C virus\u2010infected people who inject drugs in England","volume":"114","author":"Harrison","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.ijid.2020.09.1445_bib0110","unstructured":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/add.14978?af=R 23\/4\/2020."},{"key":"10.1016\/j.ijid.2020.09.1445_bib0115","series-title":"Models of HCV screening & treatment: An evidence-based international perspective. In Hepatitis C Conference 2018 Hidden Disease: The Future of Hepatitis C Treatment in the Community and Primary Care in Ireland","author":"Dillon","year":"2018"},{"key":"10.1016\/j.ijid.2020.09.1445_bib0120","article-title":"Clinical effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: a study protocol for a pragmatic cluster randomized trial","author":"Andrew","year":"2020","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.ijid.2020.09.1445_bib0125","unstructured":"https:\/\/bmjopen.bmj.com\/content\/6\/9\/e011821 23\/4\/2020."},{"issue":"April","key":"10.1016\/j.ijid.2020.09.1445_bib0130","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.drugalcdep.2017.11.031","article-title":"Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs","volume":"185","author":"Schackman","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"January","key":"10.1016\/j.ijid.2020.09.1445_bib0135","article-title":"Cost-effectiveness of the HepCATT intervention in specialist drug clinics to improve case-finding and engagement with HCV treatment for people who inject drugs in England","author":"Ward","year":"2020","journal-title":"Addiction"},{"issue":"September","key":"10.1016\/j.ijid.2020.09.1445_bib0140","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.drugpo.2017.05.042","article-title":"DOT-C: A cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitute therapy from community pharmacy","volume":"47","author":"Radley","year":"2017","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.ijid.2020.09.1445_bib0145","unstructured":"https:\/\/integrateja.eu\/ 23\/4\/2020."}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220321615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220321615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:55:46Z","timestamp":1761119746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971220321615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":29,"alternative-id":["S1201971220321615"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.09.1445","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HEPCARE EUROPE- A case study of a service innovation project aiming at improving the elimination of HCV in vulnerable populations in four European cities","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.09.1445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}